CVX vs PANW: Which Is the Better Buy?

Side-by-side comparison of Chevron Corporation and Palo Alto Networks, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Chevron Corporation Β· Energy
$188.52
-23.1% upside to fair value
Grade D
VS
Palo Alto Networks, Inc. Β· Technology
$174.96
+15.2% upside to fair value
Grade B High Quality
QuantHub Verdict
PANW has more upside to fair value (+15.2%). CVX trades at a lower forward P/E (22.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CVX PANW
Current Price $188.52 $174.96
Fair Value Estimate $145.00 $201.61
Upside to Fair Value -23.1% +15.2%
Market Cap $376.9B $119.2B
Forward P/E 22.9x 94.9x
EV / EBITDA 7.8x 52.4x
Price / Sales 1.5x 12.1x
Price / FCF 17.0x 29.3x
Revenue Growth YoY -4.6% +14.9%
Gross Margin 30.4% 73.5%
Operating Margin 9.0% 14.4%
Return on Equity 6.6% 15.5%
Dividend Yield 4.52% 0%
FCF Yield 5.89% 3.41%
Analyst Consensus Buy Strong Buy
Investment Thesis
CVX β€” Chevron Corporation
Chevron Corporation is a leading integrated oil and gas major with global upstream and downstream operations, a fortress balance sheet, and a shareholder-friendly capital return program. Under CEO Mike Wirth, the company has prioritized disciplined capital allocation, returning over $27 billion to shareholders in 2024 alone through buybacks and dividends, while maintaining a 38-year streak of con…
PANW β€” Palo Alto Networks, Inc.
Palo Alto Networks is a leading cybersecurity company specializing in AI-driven cloud security platforms, subscription services, and hardware products. The company benefits from a durable competitive moat driven by its platform transformation under CEO Nikesh Arora, with over 50% of revenue from high-margin subscription services growing at 25.6% year-over-year in fiscal 2024. Despite a premium va…
Accumulation Zones
Metric CVX PANW
Zone Low $108.75 $151.21
Zone High $123.25 $171.37
In Buy Zone? No No
← CVX Research    PANW Research β†’    All Research